Review



med associates modular chamber  (Med Associates Inc)


Bioz Verified Symbol Med Associates Inc is a verified supplier
Bioz Manufacturer Symbol Med Associates Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 97

    Structured Review

    Med Associates Inc med associates modular chamber
    Med Associates Modular Chamber, supplied by Med Associates Inc, used in various techniques. Bioz Stars score: 97/100, based on 1658 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/med associates modular chamber/product/Med Associates Inc
    Average 97 stars, based on 1658 article reviews
    med associates modular chamber - by Bioz Stars, 2026-06
    97/100 stars

    Images



    Similar Products

    97
    Med Associates Inc med associates modular chamber
    Med Associates Modular Chamber, supplied by Med Associates Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/med associates modular chamber/product/Med Associates Inc
    Average 97 stars, based on 1 article reviews
    med associates modular chamber - by Bioz Stars, 2026-06
    97/100 stars
      Buy from Supplier

    97
    Med Associates Inc med associates operant cages
    Med Associates Operant Cages, supplied by Med Associates Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/med associates operant cages/product/Med Associates Inc
    Average 97 stars, based on 1 article reviews
    med associates operant cages - by Bioz Stars, 2026-06
    97/100 stars
      Buy from Supplier

    97
    Med Associates Inc operant conditioning test chamber
    Operant Conditioning Test Chamber, supplied by Med Associates Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/operant conditioning test chamber/product/Med Associates Inc
    Average 97 stars, based on 1 article reviews
    operant conditioning test chamber - by Bioz Stars, 2026-06
    97/100 stars
      Buy from Supplier

    97
    Med Associates Inc med associates operant chambers
    Med Associates Operant Chambers, supplied by Med Associates Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/med associates operant chambers/product/Med Associates Inc
    Average 97 stars, based on 1 article reviews
    med associates operant chambers - by Bioz Stars, 2026-06
    97/100 stars
      Buy from Supplier

    97
    Med Associates Inc nose
    Nose, supplied by Med Associates Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nose/product/Med Associates Inc
    Average 97 stars, based on 1 article reviews
    nose - by Bioz Stars, 2026-06
    97/100 stars
      Buy from Supplier

    97
    Med Associates Inc mouse operant self administration chambers
    Complete experimental protocol of our mouse model of operant WIN 55,212–2 <t>intravenous</t> <t>self-administration</t>
    Mouse Operant Self Administration Chambers, supplied by Med Associates Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse operant self administration chambers/product/Med Associates Inc
    Average 97 stars, based on 1 article reviews
    mouse operant self administration chambers - by Bioz Stars, 2026-06
    97/100 stars
      Buy from Supplier

    97
    Med Associates Inc compulsive like behavior
    Complete experimental protocol of our mouse model of operant WIN 55,212–2 <t>intravenous</t> <t>self-administration</t>
    Compulsive Like Behavior, supplied by Med Associates Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/compulsive like behavior/product/Med Associates Inc
    Average 97 stars, based on 1 article reviews
    compulsive like behavior - by Bioz Stars, 2026-06
    97/100 stars
      Buy from Supplier

    97
    Med Associates Inc standard operant chamber
    Complete experimental protocol of our mouse model of operant WIN 55,212–2 <t>intravenous</t> <t>self-administration</t>
    Standard Operant Chamber, supplied by Med Associates Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/standard operant chamber/product/Med Associates Inc
    Average 97 stars, based on 1 article reviews
    standard operant chamber - by Bioz Stars, 2026-06
    97/100 stars
      Buy from Supplier

    97
    Med Associates Inc operant chamber
    Complete experimental protocol of our mouse model of operant WIN 55,212–2 <t>intravenous</t> <t>self-administration</t>
    Operant Chamber, supplied by Med Associates Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/operant chamber/product/Med Associates Inc
    Average 97 stars, based on 1 article reviews
    operant chamber - by Bioz Stars, 2026-06
    97/100 stars
      Buy from Supplier

    86
    Coy Laboratory modular hypoxia chamber
    Complete experimental protocol of our mouse model of operant WIN 55,212–2 <t>intravenous</t> <t>self-administration</t>
    Modular Hypoxia Chamber, supplied by Coy Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/modular hypoxia chamber/product/Coy Laboratory
    Average 86 stars, based on 1 article reviews
    modular hypoxia chamber - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    Image Search Results


    Complete experimental protocol of our mouse model of operant WIN 55,212–2 intravenous self-administration

    Journal: Bio-protocol

    Article Title: A Male Mouse Model of WIN 55,212–2 Self-Administration to Study Cannabinoid Addiction

    doi: 10.21769/BioProtoc.5652

    Figure Lengend Snippet: Complete experimental protocol of our mouse model of operant WIN 55,212–2 intravenous self-administration

    Article Snippet: Mouse operant self-administration chambers (Med Associates, model: ENV-307A-CT) Operant chambers are equipped with two nose-poke holes (holes of 1.2 cm diameter), one randomly selected as the active nose poke and the other as the inactive.

    Techniques:

    An intraperitoneal injection of WIN 55,212-2 (0.1 mg/kg) is administered 24 h before the first self-administration session to minimize the aversive effects of the initial cannabinoid exposure. During the first week of operant training, mice acquire WIN 55,212-2 self-administration under fixed-ratio (FR) schedules, with 5 sessions at FR1 followed by 5 sessions at FR2. Sessions 1–10 and 12 include a 15-min drug-free period (DFP), but only the latest 8–10 sessions are used to quantify persistence of responding, the first addiction-like criterion. In session 11, motivation for WIN 55,212-2 is assessed using a progressive-ratio (PR) schedule, providing the second criterion. FR2 session is then re-established in session 12 to stabilize responding before punishment testing. In session 13, compulsivity-like behavior is evaluated in a foot-shock punishment test, yielding the third diagnostic criterion and allowing classification of mice as addicted or non-addicted. Extinction training is conducted in sessions 14–23, and in session 24, a cue-induced reinstatement test is performed to probe relapse-like drug seeking and obtain the parameters related to craving.

    Journal: Bio-protocol

    Article Title: A Male Mouse Model of WIN 55,212–2 Self-Administration to Study Cannabinoid Addiction

    doi: 10.21769/BioProtoc.5652

    Figure Lengend Snippet: An intraperitoneal injection of WIN 55,212-2 (0.1 mg/kg) is administered 24 h before the first self-administration session to minimize the aversive effects of the initial cannabinoid exposure. During the first week of operant training, mice acquire WIN 55,212-2 self-administration under fixed-ratio (FR) schedules, with 5 sessions at FR1 followed by 5 sessions at FR2. Sessions 1–10 and 12 include a 15-min drug-free period (DFP), but only the latest 8–10 sessions are used to quantify persistence of responding, the first addiction-like criterion. In session 11, motivation for WIN 55,212-2 is assessed using a progressive-ratio (PR) schedule, providing the second criterion. FR2 session is then re-established in session 12 to stabilize responding before punishment testing. In session 13, compulsivity-like behavior is evaluated in a foot-shock punishment test, yielding the third diagnostic criterion and allowing classification of mice as addicted or non-addicted. Extinction training is conducted in sessions 14–23, and in session 24, a cue-induced reinstatement test is performed to probe relapse-like drug seeking and obtain the parameters related to craving.

    Article Snippet: Mouse operant self-administration chambers (Med Associates, model: ENV-307A-CT) Operant chambers are equipped with two nose-poke holes (holes of 1.2 cm diameter), one randomly selected as the active nose poke and the other as the inactive.

    Techniques: Injection, Diagnostic Assay

    Persistence was defined as non-reinforced active responses during the 15-min drug-free period across three days before the progressive-ratio (PR) session. Only the operant box house light is on during this period. Motivation was assessed with a PR schedule, with the breakpoint (last ratio completed before cessation of responding) taken as the motivation value. Only the conditioned-stimulus cue light and the drug delivery were active. Compulsivity was measured in a 50-min punished self-administration session under FR2, during which each infusion was paired with a 0.18 mA, 2 s foot shock, and the total number of shocks indexed resistance to punishment. The conditioned-stimulus cue light, the drug delivery, and the unconditioned stimulus of the grid floor delivering foot shocks were active. An overall addiction score was derived from these three behavioral measures.

    Journal: Bio-protocol

    Article Title: A Male Mouse Model of WIN 55,212–2 Self-Administration to Study Cannabinoid Addiction

    doi: 10.21769/BioProtoc.5652

    Figure Lengend Snippet: Persistence was defined as non-reinforced active responses during the 15-min drug-free period across three days before the progressive-ratio (PR) session. Only the operant box house light is on during this period. Motivation was assessed with a PR schedule, with the breakpoint (last ratio completed before cessation of responding) taken as the motivation value. Only the conditioned-stimulus cue light and the drug delivery were active. Compulsivity was measured in a 50-min punished self-administration session under FR2, during which each infusion was paired with a 0.18 mA, 2 s foot shock, and the total number of shocks indexed resistance to punishment. The conditioned-stimulus cue light, the drug delivery, and the unconditioned stimulus of the grid floor delivering foot shocks were active. An overall addiction score was derived from these three behavioral measures.

    Article Snippet: Mouse operant self-administration chambers (Med Associates, model: ENV-307A-CT) Operant chambers are equipped with two nose-poke holes (holes of 1.2 cm diameter), one randomly selected as the active nose poke and the other as the inactive.

    Techniques: Derivative Assay

    Impulsivity-like behavior was quantified as the number of non-reinforced active responses emitted during the 10-s time-out period following each WIN 55,212-2 infusion, averaged across the 3 days preceding the progressive-ratio (PR) test (higher counts indicate greater difficulty inhibiting responding once initiated). Sensitivity to reward was assessed as the total number of reinforcers earned during 2-h sessions across the last three consecutive FR2 self-administration sessions maintained by WIN 55,212-2, with higher reinforcer counts reflecting greater reward sensitivity.

    Journal: Bio-protocol

    Article Title: A Male Mouse Model of WIN 55,212–2 Self-Administration to Study Cannabinoid Addiction

    doi: 10.21769/BioProtoc.5652

    Figure Lengend Snippet: Impulsivity-like behavior was quantified as the number of non-reinforced active responses emitted during the 10-s time-out period following each WIN 55,212-2 infusion, averaged across the 3 days preceding the progressive-ratio (PR) test (higher counts indicate greater difficulty inhibiting responding once initiated). Sensitivity to reward was assessed as the total number of reinforcers earned during 2-h sessions across the last three consecutive FR2 self-administration sessions maintained by WIN 55,212-2, with higher reinforcer counts reflecting greater reward sensitivity.

    Article Snippet: Mouse operant self-administration chambers (Med Associates, model: ENV-307A-CT) Operant chambers are equipped with two nose-poke holes (holes of 1.2 cm diameter), one randomly selected as the active nose poke and the other as the inactive.

    Techniques:

    Number of total active and inactive nose pokes performed by CNO- and saline-treated groups obtained during 2 h of operant self-administration maintained by intravenous infusions of WIN 55,212-2 in both FR1 and FR2 schedules of reinforcement (mean ± S.E.M., repeated measures ANOVA). Data derived from Cajiao et al., 2023 [7].

    Journal: Bio-protocol

    Article Title: A Male Mouse Model of WIN 55,212–2 Self-Administration to Study Cannabinoid Addiction

    doi: 10.21769/BioProtoc.5652

    Figure Lengend Snippet: Number of total active and inactive nose pokes performed by CNO- and saline-treated groups obtained during 2 h of operant self-administration maintained by intravenous infusions of WIN 55,212-2 in both FR1 and FR2 schedules of reinforcement (mean ± S.E.M., repeated measures ANOVA). Data derived from Cajiao et al., 2023 [7].

    Article Snippet: Mouse operant self-administration chambers (Med Associates, model: ENV-307A-CT) Operant chambers are equipped with two nose-poke holes (holes of 1.2 cm diameter), one randomly selected as the active nose poke and the other as the inactive.

    Techniques: Saline, Derivative Assay